Information Resources for COVID-19 Response

Guidance for Law Enforcement and First Responders Administering Naloxone

Provides guidance to law enforcement and first responders on the safe use of naloxone to reverse opioid overdoses during the COVID-19 pandemic. Discusses risks of coronavirus transmission while administering naloxone for both intranasal and intramuscular forms of delivery and the use of personal protective equipment (PPE) during overdose intervention. Offers information to assist first responders with making safe decisions on the use of naloxone with the goal of reducing their risk of COVID-19 infection while continuing to provide effective response to opioid overdose emergencies.

Sponsor: Substance Abuse and Mental Health Services Administration (SAMHSA)
HUD Exchange Rural Gateway

Serves as an information clearinghouse on the U.S. Department of Housing and Urban Development (HUD) programs, services, resources, tools, and training to support housing and economic development in rural and underserved areas, including tribal populations and veterans. Offers individual technical assistance and peer learning opportunities. Includes detailed case studies of successful programs and information on rural programs HUD previously funded. Provides links to HUD resources and information in support of community responses to the COVID-19 pandemic.

Sponsor: Office of Rural Housing and Economic Development
Indian Health Service (IHS) Opioids and the COVID-19 Pandemic: Addressing the Opioid Crisis during the COVID-19 Pandemic

Outlines the impact that the COVID-19 pandemic is having on the opioid crisis in Native American and Alaskan Native families and communities across the U.S. Provides information, federal resources, programs, and services to address opioid misuse and opioid use disorder (OUD) for Native American and Alaskan Native populations during the COVID-19 crisis. Focuses on key issues and challenges, including treatment options for OUD; telehealth and remote services; prescribing requirements for buprenorphine; provider training and support; and the prevention of coronavirus transmission in high-risk environments.

Sponsor: Indian Health Service (IHS)
Office of National Drug Control Policy COVID-19 Fact Sheet

Summarizes policy changes made by federal National Drug Control Program agencies in response to the COVID-19 pandemic. Outlines program and policy changes designed to ensure individuals with substance use disorders (SUDs) can continue to safely access important treatment and recovery support services during the pandemic. Addresses several priority areas, including guidance for prevention, treatment, and recovery services; use of telemedicine and electronic prescribing, flexibility for methadone and buprenorphine treatment, access to prescribed controlled substances, support for rural and tribal communities; and relief opportunities for individuals, providers, and small businesses. Provides links to programs and agencies for additional details related to specific policy changes.

Sponsor: Office of National Drug Control Policy (ONDCP)
Rural Healthcare Surge Readiness

Provides up-to-date resources, tools, and training to help rural healthcare systems prepare for and respond to a COVID-19 surge. Addresses unique issues and challenges in emergency medical services (EMS), inpatient and hospital, ambulatory, and long-term healthcare settings, covering a wide range of related topics, including healthcare operations, telehealth, behavioral health, and more. Product of the Rural Health Information Hub funded by a cooperative agreement through HRSA's Federal Office of Rural Health Policy.

Sponsor: Federal Office of Rural Health Policy (FORHP)